Data / Form D filings / MAXCYTE, INC.
MAXCYTE, INC.: Form D filings
MAXCYTE, INC., a biotechnology company in Gaithersburg, MD, filed 4 Form D notices with the SEC between 2009 and 2016. The latest, on September 29, 2016, reports $760,308 sold of a $760,308 offering to 9 investors.
Find out what MAXCYTE, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 22 FIRSTFIELD ROAD, SUITE 110, Gaithersburg, MD, 20878
- Phone
- (301) 944-1700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1287098
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2016 | New notice | $760,308 | $760,308 | $0 | 9 | Mar 29, 2016 | sec.gov |
| Dec 16, 2014 | New notice | $1,700,000 | $1,700,000 | $0 | 21 | Dec 8, 2014 | sec.gov |
| Oct 13, 2009 | Amendment | $1,500,000 | $1,500,000 | $0 | 15 | Aug 13, 2009 | sec.gov |
| Aug 31, 2009 | New notice | $1,250,000 | $1,121,299 | $128,701 | 9 | Aug 13, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Madhusudan V Peshwa | Executive Officer | |
| J Stark Thompson | Director | |
| Douglas A Doerfler | Executive Officer, Director | |
| Arthur M Mandell | Director | |
| John Stark Johnston | Director | |
| Stanley C Erck | Director | |
| Ronald E Holtz | Executive Officer, Director | |
| Thomas M Ross | Executive Officer | |
| William Stark Brooke | Director |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Sep 26, 2016 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MAXCYTE, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.